/
MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

AMRX — Amneal Pharmaceuticals, Inc. Class A Common Stock

Nasdaq

Amneal Pharmaceuticals, Inc. Class A Common Stock

Back to Screener
$20.30
+0.23(+1.15%)
O
20.19
H
20.54
L
20.00
V
2.25M
⏱️ End-of-day dataAs of Oct 2, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Amneal Pharmaceuticals, Inc. Class A Common Stock Statistics

Total Valuation

Market Cap$6.89B
Enterprise Value$7.13B

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding319.35M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ratio106.84
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ration/a
P/TBV Ration/a
P/FCF Ration/a
P/OCF Ratio1,112.23
PEG Ration/a

Enterprise Valuation

EV / Earnings91.46
EV / Salesn/a
EV / EBITDA378.05
EV / EBIT534.20
EV / FCF-147.23

Financial Position

Current Ratio2.47
Quick Ration/a
Debt / Equity-58.19
Debt / EBITDA14.18
Debt / FCF-5.52
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)-1696.80%
Return on Assets (ROA)22.03%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$9,176
Employee Count8,500
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Tax$2.18M
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change+95.19%
50-Day Moving Average$18.32
200-Day Moving Average$15.01
Relative Strength Index (RSI)72.61
Average Volume (20 Days)2,886,173

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profit$32.01M
Operating Income$14.83M
Pretax Income$80.18M
Net Income$78.00M
EBITDA$18.87M
EBIT$13.35M
Earnings Per Share$0.19

Balance Sheet

Cash & Cash Equivalents$19.77M
Total Debt$267.50M
Net Cash-$247.73M
Net Cash Per Share$-0.78
Equity (Book Value)-$4.60M
Book Value Per Share$-0.01
Working Capital$106.99M

Cash Flow

Operating Cash Flow$6.19M
Capital Expenditures-$13.86M
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow-$48.45M
FCF Per Share$-0.15

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yield0.94%
FCF Yield-0.70%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Value$2.85
Lynch Upside-85.96%
Graham Numbern/a
Graham Upsiden/a

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a